Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mirror trick may ease Post-Stroke pain and swelling

NCT ID NCT07428811

Symptom relief Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether task-based mirror therapy can reduce pain, swelling, and improve arm function in stroke survivors who develop shoulder-hand syndrome. Thirty-four participants aged 45-75 will be split into two groups: one doing mirror therapy plus standard exercises, the other doing standard exercises alone, for 30 minutes a day, five days a week, over four weeks. Researchers will measure pain, hand swelling, and arm movement before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
task-based mirror therapy
What this could lead to
If it works, this could offer a simple, drug-free way to ease pain and swelling and improve arm movement after a stroke.
What could go wrong
This is a small, early-stage trial with only 34 participants, so results may not apply to everyone. The therapy is also time-intensive and may not work for all stroke survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 34 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age 45 to 75 years. * Both male and female patients are included in the study. * Subacute stroke patients having stroke less than 6 months are included in this study. * Stable participants having a stroke severity score \> 6 on National Institute of Health Stroke Scale (NIHSS). * Modified Ashworth scale score ≤ 2 of the affected upper extremity. * Montreal Cognitive Assessment (MoCA) score ≥ 24. * Patients who can sit with or without support. * No contractures of the affected shoulder, elbow, wrist and fingers. * Participants who have no history of peripheral nerve injury or musculoskeletal disease Exclusion Criteria: * • Participants who have medical problems or co-morbidities that interdict their participation in the study. * Patients with severe apraxia, somatosensory problems. * Unilateral neglect * Severe contractures of the affected shoulder, elbow, wrist and finger. * Participants who show the symptoms of global or receptive aphasia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-stroke shoulder-hand syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

complex regional pain syndrome complex regional pain syndrome type 1 Edema Pain stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alara healthcare clinic

    RECRUITING

    Lahore, Punjab Province, Pakistan

  • Ittefaq Hospital and Trust Lahore

    RECRUITING

    Lahore, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.